Inovio Pharmaceuticals Profit Margin

The latest profit margin for INO is 129973190.93% as of June 2026. That compares with -38380665.75% in the prior-year period — up 438.6% year over year. That is above the Industrials sector average of 10.29%. Investors often review this figure alongside Inovio Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Over the past year, INO's profit margin moved from -38380665.75% to 129973190.93% — a 438.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Inovio Pharmaceuticals's valuation or profitability profile.

Against Industrials companies, INO currently prints 129973190.93% for profit margin, while the sector average sits near 10.29%. That is roughly 1262972192.6% above the sector mean. Large gaps often invite a closer look at Inovio Pharmaceuticals's growth, margins, and balance sheet.

Profit Margin shows how effectively Inovio Pharmaceuticals converts resources into returns. At 129973190.93%, INO may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -38380665.75% in the prior-year period — up 438.6% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting INO's profit margin (129973190.93%), review year-over-year change from -38380665.75%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.